ArticleClinical drug investigation2016

Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus.

Qian Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.